Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12

Intervirology

Volumn 44, Issue 2-3, 2001, Pages 115-123

  Schirmbeck, Reinhold ^a   Reimann, Jörg ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

DNA vaccine; Hepatitis B virus; Polarization of immunity

Indexed keywords

DNA; DNA VACCINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B SURFACE ANTIGEN VACCINE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OLIGODEOXYNUCLEOTIDE; PLASMID DNA; RECOMBINANT INTERLEUKIN 12; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR IMMUNITY; CPG ISLAND; CYTOTOXIC T LYMPHOCYTE; DNA TRANSFER; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; GENE GUN; HEPATITIS B; HEPATITIS B VIRUS; IMMUNE RESPONSE; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TISSUE REACTION; VACCINATION;

ANIMALS; BIOLISTICS; CPG ISLANDS; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; PLASMIDS; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TH2 CELLS; VACCINES, DNA;

BACTERIA (MICROORGANISMS); HEPATITIS B VIRUS;

EID: 0034890076     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050038     Document Type: Article

References (41)

1. DNA vaccines
2. DNA vaccines: Immunology, application and optimization
3. DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocytes and antibody responses in mice after intramuscular injection
4. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization
5. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice
6. Immunization with soluble hepatitis B virus surface (S) protein particles elicits murine H-2 class I-restricted CD8+cytotoxic T lymphocyte responses in vivo
7. Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen
8. Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: Implication for the pathogenesis of HBV-induced hepatitis
9. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo
10. DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to hepatitis B virus surface antigen
11. Nucleic acid vaccination primes hepatitis B surface antigen-specific cytotoxic T lymphocytes in nonresponder mice
12. Hepatitis B virus surface particles are processed in a novel endosomal pathway for MHC class I-restricted epitope presentation
13. Processing of exogenous heat-aggregated (de-natured) or particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation
14. d molecules capture peptides from endocytosed, exogenous antigens for MHC class I-restricted presentation
15. d-restricted epitope presentation depends on exogenous β2m
16. Polyclonality and multispecificity of the CTL response to a single viral epitope
17. Similar as well as distinct MHC-I-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen (HBsAg)
18. Alternative processing pathways for exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation
19. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells
20. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: Antigen presentation by non-muscle cells
21. Gene vaccination with naked plasmid DNA: Mechanism of CTL priming
22. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization
23. DNA vaccines
24. Designer vaccines for parasitic diseases
25. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes
26. Applications of DNA shuffling to pharmaceuticals and vaccines
27. Selected strategies to augment polynucleotide vaccination
28. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2
29. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes
30. b-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigen
31. The role of CpG dinucleotides in DNA vaccines
32. Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination
33. Immunostimulatory DNA sequences function as T helper-1- promoting adjuvants
34. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization
35. Reduction of antigen expression from DNA vaccines by coadministered oligodeoxy-nucleotides
36. Exposing the immunology of naked DNA vaccines
37. Immune activation by bacterial DNA: A new genetic code
38. The immunologic properties of DNA
39. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination
40. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit
41. Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime